Alector

$18.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.43 (+2.42%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Alector and other stocks, options, and ETFs commission-free!

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA. The listed name for ALEC is Alector, Inc. Common Stock.

CEO
Arnon Rosenthal
Employees
121
Headquarters
South San Francisco, California
Founded
2013
Market Cap
1.41B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
599.85K
High Today
$18.53
Low Today
$17.02
Open Price
$17.57
Volume
442.61K
52 Week High
$34.89
52 Week Low
$9.12

ALEC Earnings

-$0.67
-$0.45
-$0.22
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.66 per share
Actual
-$0.66 per share

You May Also Like

IAUF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure